Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$10.50
+0.3%
$12.18
$7.17
$21.00
$478.17M1.06485,774 shs1.10 million shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$40.93
+0.2%
$35.37
$26.56
$52.41
$1.18B0.74474,233 shs471,003 shs
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$5.94
$6.55
$5.47
$10.14
$877.34M1.83673,314 shs1.99 million shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.26
+2.9%
$8.99
$8.15
$22.40
$257.89M2.1193,738 shs276,887 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
0.00%+7.91%-4.28%-43.24%+45.03%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
0.00%+8.25%+18.16%+0.29%-9.93%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
0.00%+2.24%-8.19%-21.84%-14.29%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%+5.35%+1.09%-14.26%-49.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AxoGen, Inc. stock logo
AXGN
AxoGen
2.7387 of 5 stars
3.52.00.00.02.62.50.6
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.4335 of 5 stars
3.41.00.00.02.92.50.6
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.557 of 5 stars
3.53.00.00.02.63.31.3
ZimVie Inc. stock logo
ZIMV
ZimVie
2.459 of 5 stars
3.33.00.00.02.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AxoGen, Inc. stock logo
AXGN
AxoGen
3.00
Buy$22.20111.43% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.80
Moderate Buy$52.4028.02% Upside
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.00
Buy$12.50110.44% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3376.39% Upside

Current Analyst Ratings Breakdown

Latest ZIMV, MDXG, ESTA, and AXGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/13/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$48.00
5/16/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$62.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$48.00
5/13/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $24.00
4/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AxoGen, Inc. stock logo
AXGN
AxoGen
$187.34M2.55N/AN/A$2.36 per share4.45
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$166.02M7.13N/AN/A$1.90 per share21.54
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$348.88M2.51$0.33 per share17.93$1.31 per share4.53
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.57$1.86 per share4.99$13.83 per share0.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AxoGen, Inc. stock logo
AXGN
AxoGen
-$9.96M-$0.15N/AN/AN/A-3.68%-7.09%-3.67%8/6/2025 (Estimated)
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/5/2025 (Estimated)
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$42.42M$0.2722.0018.56N/A11.40%22.70%16.77%7/30/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%7/31/2025 (Estimated)

Latest ZIMV, MDXG, ESTA, and AXGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
5/7/2025Q1 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million
4/30/2025Q1 2025
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$0.06$0.06N/A$0.05$86.32 million$88.21 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AxoGen, Inc. stock logo
AXGN
AxoGen
0.63
4.28
2.65
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
5.72
3.36
2.05
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
0.09
4.70
4.13
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48

Institutional Ownership

CompanyInstitutional Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
79.15%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
2.78%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.44%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
1.70%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
45045.54 million44.28 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,01828.92 million25.61 millionOptionable
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
870147.70 million145.19 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million26.34 millionOptionable

Recent News About These Companies

Wall Street Zen Upgrades ZimVie (NASDAQ:ZIMV) to "Strong-Buy"
ZimVie: Screening Cheap (Rating Upgrade)
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
ZimVie Reports First Quarter 2025 Financial Results
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AxoGen stock logo

AxoGen NASDAQ:AXGN

$10.50 +0.03 (+0.29%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$10.49 -0.01 (-0.10%)
As of 06/27/2025 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$40.93 +0.09 (+0.22%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$40.90 -0.03 (-0.07%)
As of 06/27/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

MiMedx Group stock logo

MiMedx Group NASDAQ:MDXG

$5.94 0.00 (0.00%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$5.94 +0.00 (+0.08%)
As of 06/27/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.26 +0.26 (+2.89%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$9.27 +0.01 (+0.11%)
As of 06/27/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.